Korea
QueryPie, the data governance platform, becomes Okta Integration Network partner in Korea
SEOUL, South Korea, June 4, 2021 /PRNewswire/ -- QueryPie, the data governance platform, now has verified integration withOkta and is available through the Okta Integration Network (OIN), for the first time in Korea. By enabling technical partnerships in addition to its affiliation with Okta's OI...
2021-06-04 21:00
4197
Hwaseung Corporation to Play Key Roles after Completing Restructuring
BUSAN, South Korea, June 4, 2021 /PRNewswire/ -- Hwaseung Corporation, the
automotive parts arm of Hwaseung Group, is intensifying efforts to improve
business efficiency after completing its corporate restructuring through a
spin-off.
2021-06-04 19:00
12996
AI-based Analysis of Cancer Tissue Predicts Response to Immunotherapy--Findings to Be Presented at ASCO 2021
* Lunit to present four abstracts including one in a 'Poster Discussion Session' * AI-based tissue analysis platform 'Lunit SCOPE' to be launched within the second half of 2021: "We aim to make our AI the new standard for cancer treatment" SEOUL, Korea, June 3, 2021 /PRNewswire/ -- A new find...
2021-06-04 02:14
3101
MoneyBrain exhibits at MWC Barcelona 2021
SEOUL, South Korea, June 3, 2021 /PRNewswire/ -- MoneyBrain, a company specialized in artificial intelligence (AI) and video synthesis, announced that they will participate in the 2021 Barcelona World Mobile Fair, so-called MWC, to be held inBarcelona at Fira de Barcelona, Fira Barcelona Gran Via...
2021-06-03 14:47
1891
PharmAbcine to Present at the BIO Digital International Convention 2021
DAEJEON, South Korea, June 2, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company will participate in BIO Digital International Convention. The company will participate in...
2021-06-02 20:00
2713
Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate
INCHEON, South Korea, June 2, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, signed a strategic partnership with KAHR Medical Ltd., a cancer immunotherapy company developing novel multifunctional immune-recruitment...
2021-06-02 19:00
2007
Bridge Biotherapeutics Announces the Initiation of the Proof of Mechanism Study for BBT-401 in Patients with Ulcerative Colitis; Rectal Delivery of Drug to Target Site
* The new proof of mechanism trial in ulcerative colitis had its first patient dosed inNew Zealand * In parallel with the oral-administered, proof of clinical principle study, the new proof of mechanism study will examine the efficacy of BBT-401 when delivered directly to the target organ via...
2021-06-02 06:00
1893
Daewoong Pharmaceutical Publishes Results of First Clinical Study of SGLT-2 Inhibitor 'Enavogliflozin' for Canine Diabetes
SEOUL, South Korea, June 1, 2021 /PRNewswire/ -- Daewoong Pharmaceutical (CEO Sengho Jeon) announced that the results of an investigator-initiated clinical study on the effect of Enavogliflozin, originally developed as Type II Diabetes Treatment forhumans, on treating canine diabetes were publish...
2021-06-01 21:00
2063
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services
* Samsung Biologics, a global leading CDMO, will add mRNA vaccine DS production capability to its existing facility by the first half of 2022 * The addition will enable Samsung Biologics to provide end-to-end mRNA vaccine manufacturing services from bulk drug substance to aseptic fill/finish ...
2021-05-31 19:00
2823
Dr. Seungpil Yu will hold a retirement ceremony and conclude his 46-year term as a pharmaceutical executive.
SEOUL, South Korea, May 28, 2021 /PRNewswire/ -- Dr. Seungpil Yu is a living witness to the long history of Yuyu Pharma, which celebrated its 80th anniversary this year, having laid the foundation for Yuyu Pharma to continue to thrive well into its 100th year. While in the United States, Dr. Yu r...
2021-05-28 21:00
3693
Samsung Biologics Adds Four Global ISO Certifications For BCMS, Energy, Health & Safety, and Environmental Management
* Expanding upon its existing ISO22301 certification, Samsung Biologics is now fully certified with Business Continuity Management System for Security and Resilience across all business areas * Samsung Biologics adds ISO50001, ISO45001, ISO14001 for Energy Management, Occupational Health and ...
2021-05-28 20:00
3303
The U.S.A., the country with the largest volume of trash production in the world, is to cash on trashes
SEOUL, South Korea, May 27, 2021 /PRNewswire/ -- Global environment company Kinava has developed a commercial plant for treating organic waste with a combined circulation that can treat even the non-combustible waste. It contains a large amount of moisture, removes air pollutants discharged to th...
2021-05-28 08:59
1658
Daewoong, first-in-class PRS-inhibitor for Idiopathic Pulmonary Fibrosis(IPF) shows promising result in early stage clinical test
* We confirmed the safety of 'DWN12088' and secured grounds for establishing treatment dosage * Confirming the potential as a treatment for IPF and planning to apply for Ph.2 within 2021 * 2nd ODD granted as treatment for systemic sclerosis from the US FDA SEOUL, South Korea, May 27, 2021...
2021-05-27 21:00
1888
LG Innotek's Quality Control Gets Recognition from a Global Premium Vehicle Maker
* LG Innotek's quality system has been certified by Jaguar Land Rover. * LG Innotek boasts quality competitiveness recognized by global companies. * LG Innotek will accelerate its effort to make inroads into the next-generation automotive component market. SEOUL, South Korea, May 26, 2021 /P...
2021-05-26 21:00
2031
Riiid raises $175 million in new funding from SoftBank Vision Fund 2
SEOUL, South Korea, May 24, 2021 /PRNewswire/ -- Riiid Inc ("Riiid"), a leading AI education company and a member ofBorn2Global Centre, has raised $175 million investment from SoftBank Vision Fund 2*. To accelerate the pace of capturing opportunities in the global education market, SoftBank Visio...
2021-05-25 09:42
2645
A 'Game Changer' COVID-19 drug from Korea was introduced in a world class academic journal
SEOUL South Korea, May 23, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced on the 24th that CNPharm, its major shareholding bio tech company, published an article containing the research results of CP-COV03, a Niclosamide-based oral treatment for COVID-19 based on its proprietar...
2021-05-24 08:16
2435
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine
CAMBRIDGE, Mass. and INCHEON, South Korea, May 22, 2021 /PRNewswire/ -- Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics (KRX: 207940.KS), a leading global CDMO providing a fully integrated end-to-end contract develop...
2021-05-23 00:00
9639
CUREXO's spinal surgery robot, 'CUVIS-spine' acquired FDA (US) licensing.
* 'CUVIS-spine' is available in all countries by acquiring the license from the FDA (US), Korea andEurope. * 'CUVIS-spine' reduces surgery duration with Minimally Invasive Surgery (MIS). SEOUL, South Korea, May 21, 2021 /PRNewswire/ -- On the 20th, the Medical robot specialist company CUREX...
2021-05-22 03:52
3658
LG Display Brings Next-Generation OLED Solutions to SID 2021
SEOUL, South Korea, May 16, 2021 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today that it will showcase its differentiated OLED products at the 'SID (Society for Information Display) 2021' exhibition to be held online between the 17th and 21st of ...
2021-05-17 09:00
6182
Arctic Vision announces exclusive licensing agreement with ActualEyes
To develop and commercialize cell therapy to potentially replace corneal endothelial keratoplasty inGreater China and South Korea * Arctic Vision to partner with ActualEyes to introduce novel approach of using cultured corneal endothelial cells to treat corneal endothelial dysfunction and pote...
2021-05-14 20:00
3270
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 315 media titles]
2026-01-23 11:03
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 305 media titles]
2026-01-23 09:00AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 302 media titles]
2026-01-21 12:39Government of Telangana and Blaize Sign MoU at Davos to Launch Telangana AI Innovation Hub and Advance Applied AI Initiatives
[Picked up by 297 media titles]
2026-01-22 15:16
Klook's study of 374,000 reviews finds that lesser-known cities create deeper emotional connection with travelers
[Picked up by 280 media titles]
2026-01-20 15:40
Most Read
Building the Run: Xtep Charts a New Community Ecosystem in Southeast Asia
2026-01-20 17:49
6137
